RELASIGEBLAH7hhaider5  

PubMed@dpavot:33053024_en_relations JSONTXT 5 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T40 4-13 CHEBI_41879 denotes infection
T0 28-34 HP_0012828 denotes severe
T1 28-61 DOID_2945 denotes severe acute respiratory syndrome
T43 28-88 CHEBI_41879 denotes severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
T2 35-40 HP_0011009 denotes acute
T39 41-52 CHEBI_41879 denotes respiratory
T3 53-61 DOID_225 denotes syndrome
T41 77-87 CHEBI_41879 denotes SARS-CoV-2
T4 170-190 DOID_0080600 denotes SARS-CoV-2 infection
T5 204-211 DOID_4 denotes disease
T6 219-227 DOID_0080600 denotes COVID-19
T7 232-247 DOID_10533 denotes viral pneumonia
T8 238-247 HP_0002090 denotes pneumonia
T9 238-247 DOID_552 denotes pneumonia
T42 272-294 CHEBI_41879 denotes respiratory compromise
T10 348-353 HP_0011009 denotes acute
T11 348-383 DOID_11394 denotes acute respiratory distress syndrome
T12 354-374 HP_0002098 denotes respiratory distress
T13 375-383 DOID_225 denotes syndrome
T14 423-427 CHEBI_50906 denotes role
T15 431-446 CHEBI_50858 denotes corticosteroids
T16 463-468 HP_0011009 denotes acute
T17 463-498 DOID_11394 denotes acute respiratory distress syndrome
T18 469-489 HP_0002098 denotes respiratory distress
T19 490-498 DOID_225 denotes syndrome
T20 596-609 CHEBI_41879 denotes dexamethasone
T44 665-687 CHEBI_41879 denotes mechanical ventilation
T21 746-754 HP_0012826 denotes moderate
T22 758-764 HP_0012828 denotes severe
T23 765-770 HP_0011009 denotes acute
T24 765-800 DOID_11394 denotes acute respiratory distress syndrome
T25 771-791 HP_0002098 denotes respiratory distress
T26 792-800 DOID_225 denotes syndrome
T27 830-838 DOID_0080600 denotes COVID-19
T28 1021-1029 HP_0012826 denotes moderate
T29 1033-1039 HP_0012828 denotes severe
T30 1040-1045 HP_0011009 denotes acute
T31 1040-1075 DOID_11394 denotes acute respiratory distress syndrome
T32 1046-1066 HP_0002098 denotes respiratory distress
T33 1067-1075 DOID_225 denotes syndrome
T45 1088-1107 CHEBI_41879 denotes the Berlin criteria
T34 1116-1124 DOID_0080600 denotes COVID-19
T35 1205-1218 CHEBI_41879 denotes dexamethasone
T36 1270-1283 CHEBI_41879 denotes dexamethasone
T37 1349-1362 CHEBI_41879 denotes dexamethasone
T38 1415-1428 CHEBI_41879 denotes dexamethasone
R0 T1 T14 no_relation severe acute respiratory syndrome,role
R1 T1 T15 negative severe acute respiratory syndrome,corticosteroids
R10 T5 T20 effect disease,dexamethasone
R11 T5 T35 effect disease,dexamethasone
R12 T6 T14 no_relation COVID-19,role
R13 T6 T15 negative COVID-19,corticosteroids
R14 T6 T20 effect COVID-19,dexamethasone
R15 T6 T35 effect COVID-19,dexamethasone
R16 T7 T14 no_relation viral pneumonia,role
R17 T7 T15 negative viral pneumonia,corticosteroids
R18 T7 T20 effect viral pneumonia,dexamethasone
R19 T7 T35 effect viral pneumonia,dexamethasone
R2 T1 T20 effect severe acute respiratory syndrome,dexamethasone
R20 T13 T14 no_relation syndrome,role
R21 T13 T15 no_relation syndrome,corticosteroids
R22 T13 T20 effect syndrome,dexamethasone
R23 T13 T35 effect syndrome,dexamethasone
R24 T17 T14 no_relation acute respiratory distress syndrome,role
R25 T17 T15 effect acute respiratory distress syndrome,corticosteroids
R26 T17 T20 effect acute respiratory distress syndrome,dexamethasone
R27 T17 T35 effect acute respiratory distress syndrome,dexamethasone
R28 T24 T14 no_relation acute respiratory distress syndrome,role
R29 T24 T15 effect acute respiratory distress syndrome,corticosteroids
R3 T1 T35 effect severe acute respiratory syndrome,dexamethasone
R30 T24 T20 effect acute respiratory distress syndrome,dexamethasone
R31 T24 T35 effect acute respiratory distress syndrome,dexamethasone
R32 T27 T14 no_relation COVID-19,role
R33 T27 T15 effect COVID-19,corticosteroids
R34 T27 T20 effect COVID-19,dexamethasone
R35 T27 T35 effect COVID-19,dexamethasone
R36 T33 T14 no_relation syndrome,role
R37 T33 T15 no_relation syndrome,corticosteroids
R38 T33 T20 no_relation syndrome,dexamethasone
R39 T33 T35 effect syndrome,dexamethasone
R4 T4 T14 no_relation SARS-CoV-2 infection,role
R40 T34 T14 no_relation COVID-19,role
R41 T34 T15 effect COVID-19,corticosteroids
R42 T34 T20 effect COVID-19,dexamethasone
R43 T34 T35 effect COVID-19,dexamethasone
R45 T41 T40 effect SARS-CoV-2,infection
R46 T41 T5 effect SARS-CoV-2,disease
R47 T41 T6 effect SARS-CoV-2,COVID-19
R48 T41 T9 effect SARS-CoV-2,pneumonia
R49 T41 T7 effect SARS-CoV-2,viral pneumonia
R5 T4 T15 effect SARS-CoV-2 infection,corticosteroids
R50 T42 T41 effect respiratory compromise,SARS-CoV-2
R51 T11 T41 effect acute respiratory distress syndrome,SARS-CoV-2
R52 T15 T41 Negative corticosteroids,SARS-CoV-2
R53 T20 T41 effect dexamethasone,SARS-CoV-2
R54 T44 T42 effect mechanical ventilation,respiratory compromise
R55 T27 T41 effect COVID-19,SARS-CoV-2
R56 T45 T31 effect the Berlin criteria,acute respiratory distress syndrome
R57 T45 T6 effect the Berlin criteria,COVID-19
R58 T6 T45 effect COVID-19,the Berlin criteria
R59 T45 T9 effect the Berlin criteria,pneumonia
R6 T4 T20 effect SARS-CoV-2 infection,dexamethasone
R60 T8 T45 effect pneumonia,the Berlin criteria
R61 T45 T7 effect the Berlin criteria,viral pneumonia
R62 T40 T43 effect infection,severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
R63 T44 T6 effect mechanical ventilation,COVID-19
R7 T4 T35 effect SARS-CoV-2 infection,dexamethasone
R8 T5 T14 no_relation disease,role
R9 T5 T15 effect disease,corticosteroids